Why is Artemis Medicare falling/rising?

As of 01-Sep, Artemis Medicare Services Ltd is experiencing a price increase, currently at Rs 229.20, reflecting a rise of 10.4 or 4.75%. Today's price summary indicates that the stock outperformed its sector by 3.89% and reached an intraday high of Rs 230.1, marking a 5.16% increase. However, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the longer term. Despite a significant annual growth rate in operating profit of 49.66% and positive results over the last six quarters, the stock has underperformed in the past year with a return of -19.79%, while profits have risen by 55.8%. The presence of pledged promoter shares (44.53%) and low management efficiency, indicated by a low ROE of 8.11%, may also contribute to investor concerns.
In the broader market context, Artemis Medicare's short-term performance over the past week shows a decline of 1.25%, which is slightly better than the Sensex's drop of 1.56%. However, the stock's year-to-date performance is notably poor, with a decline of 26.98% compared to a 2.85% increase in the benchmark index. This underperformance highlights the challenges the company faces in gaining investor confidence, particularly in light of its high pledged shares and low profitability metrics. Overall, while there are positive indicators regarding growth and valuation, the stock's recent movements reflect a complex interplay of investor sentiment and market conditions.